PERCEPTIVE ADVISORS LLC Q3 2017 Filing
Filed November 14, 2017
Portfolio Value
$2.6T
Holdings
134
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (134 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NBIXNEUROCRINE BIOSCIENCES INC | 4,791,589 | $293.6B | 11.21% | |
| 2 | AM6AMICUS THERAPEUTICS INC | 17,888,597 | $269.8B | 10.30% | |
| 3 | ALNYALNYLAM PHARMACEUTICALS | 1,788,802 | $210.2B | 8.02% | |
| 4 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 4,264,066 | $132.4B | 5.05% | |
| 5 | —ZOGENIX INC | 3,670,357 | $128.6B | 4.91% | |
| 6 | PBYIPUMA BIOTECHNOLOGY INC | 923,820 | $110.6B | 4.22% | |
| 7 | —LA JOLLA PHARMACEUTICAL CO | 2,157,011 | $75.0B | 2.86% | |
| 8 | —RETROPHIN INC | 2,686,204 | $66.9B | 2.55% | |
| 9 | —AVEXIS INC | 671,181 | $64.9B | 2.48% | |
| 10 | —CORIUM INTL INC | 5,847,133 | $64.8B | 2.47% | |
| 11 | XLRNACCELERON PHARMA INC | 1,616,259 | $60.3B | 2.30% | |
| 12 | —TESARO INC | 388,651 | $50.2B | 1.91% | |
| 13 | RGNXREGENXBIO INC | 1,441,186 | $47.5B | 1.81% | |
| 14 | —DOVA PHARMACEUTICALS INC | 1,754,015 | $42.6B | 1.63% | |
| 15 | IOVAIOVANCE BIOTHERAPEUTICS INC | 4,726,114 | $36.6B | 1.40% | |
| 16 | —NXSTAGE MEDICAL INC | 1,264,523 | $34.9B | 1.33% | |
| 17 | ANABANAPTYSBIO INC | 982,269 | $34.3B | 1.31% | |
| 18 | AKBAAKEBIA THERAPEUTICS INC | 1,630,000 | $32.1B | 1.22% | |
| 19 | XNCRXENCOR INC | 1,293,095 | $29.6B | 1.13% | |
| 20 | 2L9BLUEPRINT MEDICINES CORP | 424,661 | $29.6B | 1.13% | |
| 21 | —DBV TECHNOLOGIES S A | 1,126,419 | $27.3B | 1.04% | Put |
| 22 | ISRGINTUITIVE SURGICAL INC | 25,195 | $26.4B | 1.01% | |
| 23 | VAC2USDVBI VACCINES INC | 6,565,843 | $25.3B | 0.96% | |
| 24 | CTMXCYTOMX THERAPEUTICS INC | 1,390,381 | $25.3B | 0.96% | |
| 25 | HUMHUMANA INC | 100,000 | $24.4B | 0.93% | |
| 26 | —MYOKARDIA INC | 550,717 | $23.6B | 0.90% | |
| 27 | ALDXALDEYRA THERAPEUTICS INC | 3,085,458 | $22.2B | 0.85% | |
| 28 | —AUDENTES THERAPEUTICS INC | 781,309 | $21.9B | 0.84% | |
| 29 | SELBUSDSELECTA BIOSCIENCES INC | 1,162,325 | $21.2B | 0.81% | |
| 30 | VRTXVERTEX PHARMACEUTICALS INC | 138,626 | $21.1B | 0.80% | |
| 31 | GLPGGALAPAGOS N V | 206,405 | $21.0B | 0.80% | |
| 32 | IRTCIRHYTHM TECHNOLOGIES INC | 372,671 | $19.3B | 0.74% | |
| 33 | CBAYUSDCYMABAY THERAPEUTICS INC | 2,350,882 | $18.9B | 0.72% | |
| 34 | —QUOTIENT TECHNOLOGY INC | 3,726,986 | $18.4B | 0.70% | |
| 35 | BDQMALBIREO PHARMA INC | 845,000 | $17.7B | 0.68% | |
| 36 | NVTA1EURINVITAE CORP | 1,884,500 | $17.7B | 0.67% | |
| 37 | —KADMON HLDGS INC | 5,185,847 | $17.4B | 0.66% | |
| 38 | AVDLAVADEL PHARMACEUTICALS PLC | 1,549,005 | $16.3B | 0.62% | |
| 39 | —SPARK THERAPEUTICS INC | 180,000 | $16.0B | 0.61% | |
| 40 | —ABEONA THERAPEUTICS INC | 1,259,636 | $15.8B | 0.60% | |
| 41 | —ALLIQUA BIOMEDICAL INC | 4,233,951 | $15.5B | 0.59% | |
| 42 | ASMBASSEMBLY BIOSCIENCES INC | 441,833 | $15.4B | 0.59% | |
| 43 | EVHEVOLENT HEALTH INC | 850,000 | $15.1B | 0.58% | |
| 44 | ITCIEURINTRA CELLULAR THERAPIES INC | 929,460 | $14.7B | 0.56% | |
| 45 | —ANTARES PHARMA INC | 4,353,897 | $14.1B | 0.54% | |
| 46 | WVEWAVE LIFE SCIENCES LTD | 642,798 | $14.0B | 0.53% | |
| 47 | TFXTELEFLEX INC | 55,200 | $13.4B | 0.51% | |
| 48 | —SYNLOGIC INC | 686,352 | $13.1B | 0.50% | |
| 49 | —AVEO PHARMACEUTICALS INC | 3,415,116 | $12.6B | 0.48% | |
| 50 | —BIOHAVEN PHARMACTL HLDG CO L | 306,134 | $11.4B | 0.44% | |
| 51 | ARDXARDELYX INC | 18,105,281 | $10.1B | 0.39% | |
| 52 | ARGXARGENX SE | 450,000 | $10.1B | 0.39% | |
| 53 | QUREUNIQURE NV | 1,040,119 | $10.0B | 0.38% | |
| 54 | ABMDEURABIOMED INC | 51,729 | $8.7B | 0.33% | |
| 55 | —ATHENAHEALTH SHARES | 70,000 | $8.7B | 0.33% | |
| 56 | —MARINUS PHARMACEUTICALS | 1,452,700 | $8.5B | 0.33% | |
| 57 | URGNUROGEN PHARMA LTD | 269,014 | $8.5B | 0.32% | |
| 58 | —ANI PHARMACEUTICALS | 7,500,000 | $8.1B | 0.31% | |
| 59 | —OXFORD IMMUNOTEC GLOBAL PLC | 465,356 | $7.8B | 0.30% | |
| 60 | —CAPITAL SR LIVING CORP | 560,173 | $7.0B | 0.27% | |
| 61 | EXASEXACT SCIENCES CORP | 135,444 | $6.4B | 0.24% | |
| 62 | —CLEMENTIA PHARMACEUTICALS IN | 352,250 | $6.3B | 0.24% | |
| 63 | —FOAMIX PHARMACEUTICALS LTD | 1,117,324 | $6.2B | 0.24% | |
| 64 | —ZYMEWORKS INC | 730,768 | $5.8B | 0.22% | |
| 65 | —ACELRX PHARMACEUTICALS INC | 1,244,608 | $5.7B | 0.22% | |
| 66 | —SIERRA ONCOLOGY INC | 3,655,186 | $5.7B | 0.22% | |
| 67 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 340,000 | $5.5B | 0.21% | Call |
| 68 | HRTXHERON THERAPEUTICS INC | 330,000 | $5.3B | 0.20% | |
| 69 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 620,181 | $5.1B | 0.20% | |
| 70 | ZLABZAI LAB LTD | 175,000 | $4.7B | 0.18% | |
| 71 | —ONCOMED PHARMACEUTICALS INC | 1,038,289 | $4.7B | 0.18% | |
| 72 | —VERSARTIS INC | 1,888,160 | $4.6B | 0.18% | |
| 73 | —NEWLINK GENETICS CORP | 450,000 | $4.6B | 0.17% | |
| 74 | MMSIMERIT MEDICAL SYS INC | 100,000 | $4.2B | 0.16% | |
| 75 | —MOLECULAR TEMPLATES INC | 724,133 | $4.2B | 0.16% | |
| 76 | —NEPTUNE TECHNOLOGIES BIORESO | 6,519,634 | $4.1B | 0.16% | |
| 77 | IVCUSDINVACARE CORP | 200,000 | $4.0B | 0.15% | |
| 78 | —GW PHARMACEUTICALS PLC | 36,763 | $3.7B | 0.14% | |
| 79 | —NUCANA PLS | 200,000 | $3.7B | 0.14% | |
| 80 | —HISTOGENICS CORP | 1,777,777 | $3.5B | 0.13% | |
| 81 | RGENREPLIGEN INC | 87,400 | $3.3B | 0.13% | |
| 82 | GILDGILEAD SCIENCES INC | 40,000 | $3.2B | 0.12% | |
| 83 | VRNAVERONA PHARMA PLC | 200,000 | $3.1B | 0.12% | |
| 84 | CRBPEURCORBUS PHARMACEUTICALS HLDGS | 414,684 | $3.0B | 0.11% | |
| 85 | —PFENEX INC | 845,973 | $2.6B | 0.10% | |
| 86 | —VIVEVE MEDICAL INC | 486,988 | $2.6B | 0.10% | |
| 87 | ALNYALNYLAM PHARMACEUTICALS INC | 520,000 | $2.4B | 0.09% | Put |
| 88 | —OCERA THERAPEUTICS INC | 2,038,880 | $2.3B | 0.09% | |
| 89 | —MGC DIAGNOSTICS CORP | 252,327 | $2.3B | 0.09% | |
| 90 | ADMAADMA BIOLOGICS INC | 721,102 | $2.2B | 0.08% | |
| 91 | MCRB1EURSERES THERAPEUTICS INC | 135,000 | $2.2B | 0.08% | |
| 92 | —ABEONA THERAPEUTICS INC | 116,900 | $2.0B | 0.08% | |
| 93 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 102,500 | $1.9B | 0.07% | |
| 94 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 157,679 | $1.7B | 0.07% | |
| 95 | BCLIEURBRAINSTORM CELL THERAPEUTICS | 400,000 | $1.6B | 0.06% | |
| 96 | —AFFIMED N V | 668,214 | $1.5B | 0.06% | |
| 97 | —XENON PHARMACEUTICALS INC | 503,853 | $1.5B | 0.06% | |
| 98 | CSBRCHAMPIONS ONCOLOGY INC | 386,540 | $1.4B | 0.05% | |
| 99 | —CURIS INC | 951,201 | $1.4B | 0.05% | |
| 100 | —ZYNERBA PHARMACEUTICALS INC | 130,700 | $1.3B | 0.05% |
Page 1 of 2Next